Skip to main content
Premium Trial:

Request an Annual Quote

Biothreat Detection Tech Firm BioFlyte Raises $6.1M in Series A Round

NEW YORK — Biothreat detection technology firm BioFlyte said on Tuesday that it has raised $6.1 million in Series A funding.

The financing round was led by Cottonwood Technology Fund and included existing investor Anzu Partners.

Albuquerque, New Mexico-based BioFlyte was spun off in 2020 from Zeteo Tech, which develops environmental air testing technologies, to commercialize systems for detecting SARS-CoV-2 and other airborne pathogens.

BioFlyte said that it will use the Series A money to support the field validation and initial production of BioTOF z200, a matrix-assisted laser desorption and ionization mass spectrometry-based bio-aerosol detection system for continuous and autonomous operation in critical infrastructure environments. The system consists of a wall mount sensor designed to detect and identify airborne microbes and toxins in real time, the company said. It is expected to launch commercially before the end of the year.

BioFlyte previously raised $1.25 million in seed funding.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.